Within the large-scale, European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we sought to comprehensively assess associations of five existing proteomic clocks, a novel “Global” proteomic age clock, and organ specific clocks with risk of mortality, cardiometabolic diseases, neurodegenerative diseases and cancers. The gene discussed is CLOCK; the disease is neurodegenerative disease.